Clinical Pediatric Emergency Medicine
Volume 6, Issue 2 , Pages 68-75 , June 2005

Epidemiology of Pediatric Poison Exposures: An Analysis of 2003 Poison Control Center Data

  • Toby Litovitz, MD

      Affiliations

    • American Association of Poison Control Centers, Washington, DC
    • Corresponding Author InformationReprint requests and correspondence: Dr. Toby Litovitz, MD, Director, American Association of Poison Control Centers, 3201 New Mexico Ave, Suite 310, Washington, DC 20016.
    • ,
  • Nicole C. White

      Affiliations

    • Princeton University, Princeton, NJ
    • ,
  • William A. Watson, PharmD

      Affiliations

    • American Association of Poison Control Centers, Washington, DC

References 

  1. Watson WA, Litovitz TL, Klein-Schwartz W, et al. 2003 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2004;22:335–404
  2. Litovitz T. The TESS database: use in product safety assessment. Drug Saf. 1998;18:9–19
  3. Miller TR, Lestina DC. Cost of poisoning in the United States and savings from poison control centers: a benefit-cost analysis. Ann Emerg Med. 1997;29:239–245
  4. House of Representatives Committee on Government Operations. Poison control centers: On the brink of extinction. Thirteenth report by the Committee on Government Operations. 103d Congress, 2d session, House Report 103-860, October 19, 1994.
  5. Litovitz T, Manoguerra A. Comparison of pediatric poisoning hazards: an analysis of 3.8 million exposure incidents. Pediatrics. 1992;89:999–1006
  6. Food and Drug Administration. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Fed Regist. 2004;69:6787–6854[February 11]
  7. Morris CC. Pediatric iron poisonings in the United States. South Med J. 2000;93:352–358
  8. Caravati EM, Litovitz TL. Pediatric cyanide intoxication and death from an acetonitrile-containing cosmetic. JAMA. 1988;260:3470–3473
  9. Consumer Product Safety Commission. Requirements for child resistant packaging. Requirements for products containing dibucaine or lidocaine, final rule. Fed Regist. 1995;60:17992–18005[April 10]

PII: S1522-8401(05)00051-0

doi: 10.1016/j.cpem.2005.04.001

Clinical Pediatric Emergency Medicine
Volume 6, Issue 2 , Pages 68-75 , June 2005

Article Tools

* Image Usage & Resolution